Blood Drug Testing for Cannabis
Blood is the best single specimen for detecting recent cannabis use, but it is rarely used in workplace testing. Its primary applications are DUI investigations, post-accident testing, insurance medical exams, and research studies. Blood tests measure parent THC and its metabolites directly.
What Blood Tests Detect
Unlike urine tests, blood tests typically measure three cannabinoids:
- Δ9-THC — the psychoactive parent drug. Peak plasma concentrations occur within minutes of inhalation.
- 11-OH-THC — the psychoactive intermediate metabolite. Proportionally higher after edible ingestion due to first-pass hepatic metabolism.
- THC-COOH — the inactive terminal metabolite. Can persist in blood for days in chronic users.
Because blood contains parent THC directly, blood tests give a closer (though still imperfect) relationship to recent use than urine tests do.
Detection Windows in Blood
| Usage Pattern | Parent THC Detectable | Notes |
|---|---|---|
| Single use | 3–12 hours | Peak within minutes; drops below detection limit quickly |
| Occasional (1–2x/week) | 12–24 hours | |
| Regular (several/week) | 1–3 days | |
| Heavy/daily | 2–7 days | |
| Chronic heavy | Up to 25–30 days | Bergamaschi 2013 (PMID 23449702) documented blood THC persisting up to 30 days in chronic daily smokers during monitored abstinence |
Where Blood Tests Are Used
DUI and DWI Investigations
This is the primary real-world use of cannabis blood testing in the United States. Several states have enacted per se blood THC limits:
- Colorado and Washington: 5 ng/mL — permissible inference of impairment
- Ohio and Nevada: 2 ng/mL
- Pennsylvania: 1 ng/mL
- ~10 states: Zero tolerance for any detectable THC
The AAA Foundation for Traffic Safety has concluded these per se laws are "arbitrary and unsupported by science." A 5 ng/mL limit misses 70% of cannabis-impaired drivers while ensnaring sober frequent users. See DUI Testing for the full discussion.
Post-Accident Workplace Testing
After serious workplace accidents, employers may order blood testing to establish whether drugs were involved. Blood is preferred over urine for post-accident testing because it is more plausibly related to impairment at the time of the incident — though the same chronic-user caveat applies.
Research Studies
Controlled pharmacology studies typically use blood because it is the clinical standard for measuring drug concentrations. The key citations in this field (Huestis, Karschner, Bergamaschi) are based on plasma THC measurements.
Life Insurance Medical Exams
Life insurance underwriting sometimes includes blood tests, which can identify cannabis use for classification purposes. Different insurers treat cannabis differently; some classify marijuana users as smokers (higher premiums), others distinguish consumption method. See Insurance.
Limitations of Blood Testing
- Poor correlation with impairment in chronic users — stored THC slowly re-enters circulation
- Short window for parent THC in occasional users — can miss recent use if test is not prompt
- Invasive collection — requires a trained phlebotomist, more expensive than urine
- Not federally authorized for SAMHSA or DOT workplace drug testing programs
- Per se limits are scientifically indefensible for cannabis, but are legally enforceable regardless
Blood Collection Procedure
Blood for forensic testing is collected via venipuncture by a trained phlebotomist. Samples are typically drawn into gray-top tubes (sodium fluoride and potassium oxalate) which inhibit enzymatic degradation of THC. Chain of custody is maintained throughout transport and lab handling.
Whole blood vs. serum vs. plasma distinctions matter for interpretation. THC partitions into red blood cells and plasma proteins; whole blood concentrations are typically about half of plasma concentrations. When reading research or forensic reports, pay attention to which matrix is specified.
Cost
- Basic blood cannabinoid panel: $50–100
- Quantitative forensic panel: $150–200+
- Full forensic toxicology with chain of custody: $200–500+